Cargando…

New therapies to treat inherited cardiomyopathies are on the way

Detalles Bibliográficos
Autores principales:	Vlasman, P., van der Velden, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2022
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799817/ https://www.ncbi.nlm.nih.gov/pubmed/35060106 http://dx.doi.org/10.1007/s12471-021-01657-5

Ejemplares similares

The contribution of mutations in MYH7 to the onset of cardiomyopathy
por: Bollen, I. A. E., et al.
Publicado: (2017)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

Gene therapy to treat inherited and complex retinal degenerative diseases
por: Rex, Tonia S
Publicado: (2015)

Individual, societal and clinical burden of cardiovascular disease: health technology assessment to guide new diagnostics and treatment strategies
por: van der Velden, Jolanda
Publicado: (2023)

E-Health: a novel way to redesigning healthcare
por: van der Wall, E. E.
Publicado: (2016)

The young ones and the old: past & future of science
por: van der Velden, J., et al.
Publicado: (2014)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Molecular autopsy
por: van Driel, B., et al.
Publicado: (2018)

Heart failure with preserved ejection fraction: current status and challenges for the future
por: van der Velden, J., et al.
Publicado: (2016)

Increasing sensitivity—a common-sense approach?
por: Michels, M., et al.
Publicado: (2019)

Paving the way to improve therapy for Myeloproliferative Neoplasms
por: Bywater, Megan, et al.
Publicado: (2022)

Untying the knot: protein quality control in inherited cardiomyopathies
por: Dorsch, Larissa M., et al.
Publicado: (2018)

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
por: de Groot, Joris R.
Publicado: (2023)

Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019)

Left cardiac sympathetic denervation for the treatment of inherited arrhythmia syndromes: salvation for the desperate?
por: Voskuil, M., et al.
Publicado: (2014)

A critical view on transgenerational epigenetic inheritance in humans
por: Horsthemke, Bernhard
Publicado: (2018)

Current aspects of cardiac resynchronisation therapy
por: Meine, M., et al.
Publicado: (2015)

Improvement in CRT: new strategies, better choices
por: van der Wall, E. E.
Publicado: (2014)

Stem cell therapy for heart disease: truly beneficial?
por: van der Wall, E. E.
Publicado: (2014)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
por: Walsh, R., et al.
Publicado: (2021)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Conflicts of interest: call for new editorial policies in European national journals
por: van der Wall, E. E.
Publicado: (2012)

New insights in prevention, diagnosis and treatment of stroke: its relation with atrial fibrillation
por: van der Wall, E. E.
Publicado: (2012)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

The microbiome in precision medicine: the way forward
por: Petrosino, Joseph F.
Publicado: (2018)

Echocardiography in takotsubo cardiomyopathy; a useful approach?
por: van der Wall, E. E., et al.
Publicado: (2010)

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
por: van der Wall, E. E.
Publicado: (2009)

Dynactin polices two-way organelle traffic
por: Dell, Karen R.
Publicado: (2003)

Zoonotic tuberculosis in Africa: challenges and ways forward
por: Carruth, Lauren, et al.
Publicado: (2016)

Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality
por: van der Wall, E. E., et al.
Publicado: (2008)

Treating hypoplastic left heart syndrome in emerging economies: Heading the wrong way?
por: Iyer, Krishna S
Publicado: (2013)

A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies
por: Wiethoff, Isabell, et al.
Publicado: (2023)

Long COVID: the next public health crisis is already on its way
por: Yang, Chengliang, et al.
Publicado: (2023)

Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
por: Konnick, Eric Q., et al.
Publicado: (2016)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Pandemic preparedness in the 21st century: which way forward?
por: Khor, Swee Kheng, et al.
Publicado: (2021)

Five ways team leaders can improve research culture
por: Ayres, Zoë
Publicado: (2021)

How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412
por: Kataoka, Naoya, et al.
Publicado: (2023)

The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
por: van der Heijden, J. F., et al.
Publicado: (2013)

Inherited Syphilis
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_uq5g7102a5rmdo5f0osjf6b0g7